Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1804 studies found for:    breast,cancer,treatment | Open Studies
Show Display Options
Download search resultsDownload the search results for:
breast,cancer,treatment | Open Studies (1804 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Economic and Social Disparities and Breast Cancer
Condition: Breast Cancer
Interventions: Other: Exposed;   Other: Non exposed
2 Not yet recruiting Eliminating Breast Cancer Surgery in Exceptional Responders With Neoadjuvant Therapy
Condition: Breast Cancer Female
Interventions: Procedure: Breast Biopsy;   Radiation: Radiation Therapy;   Behavioral: Questionnaire
3 Recruiting Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition: HR+ HER2- Postmenopausal Advanced Breast Cancer
Interventions: Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant;   Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
4 Not yet recruiting A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
Conditions: Breast Cancer;   Estrogen Receptor Positive Breast Cancer;   Node-negative Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Interventions: Other: Breast Cancer Treatment Decision Aid for women 70+;   Other: Usual Care
5 Recruiting Intraoperative Radiation Therapy in Early Stage Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Intraoperative Radiation Therapy
6 Recruiting Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy
Condition: Breast Neoplasms
Intervention: Procedure: Completion axillary treatment
7 Recruiting A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Condition: Breast Cancer
Interventions: Drug: Capecitabine;   Procedure: endocrine therapy
8 Recruiting Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
Condition: Breast Cancer
Intervention: Radiation: Adjuvant Hypofractionated Radiation
9 Recruiting Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Condition: Early Breast Cancer
Intervention: Other: Endocrine therapy interruption
10 Recruiting Assessment of Fatigue During Radiotherapy for Breast Cancer With and Without Homeopathy Treatment
Condition: Breast Cancer
Interventions: Other: Homeopathy remedy;   Radiation: Radiation as adjuvant therapy for breast cancer
11 Recruiting Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Conditions: Breast Cancer;   Early Stage;   Triple Negative Breast Cancer
Interventions: Drug: Enzalutamide;   Behavioral: assessment
12 Not yet recruiting EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
Condition: Early Stage Breast Carcinoma
Intervention: Radiation: Omission of radiation therapy
13 Recruiting POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer
Condition: Breast Cancer
Interventions: Other: Adjuvant therapy;   Procedure: Axillary treatment
14 Recruiting Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Drug: Tamoxifen;   Drug: Palbociclib;   Drug: Endocrine Therapy
15 Recruiting Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer
Conditions: Tumors;   Breast Cancer
Intervention: Radiation: intensity modulated radiotherapy (IMRT) for breast cancer
16 Recruiting PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Condition: Breast Cancer
Interventions: Drug: Neoadjuvant tamoxifen + goserelin (premenopausal women);   Drug: Neoadjuvant letrozole (postmenopausal women);   Drug: Neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone);   Drug: Neoadjuvant docetaxel + cyclophosphamide;   Drug: Neoadjuvant docetaxel;   Drug: Neoadjuvant docetaxel + trastuzumab + pertuzumab;   Drug: Neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab;   Drug: Neoadjuvant olaparib;   Drug: Neoadjuvant olaparib + carboplatin (if lack of response to olaparib alone);   Procedure: Breast conserving surgery or mastectomy + SNB/axillary dissection;   Radiation: Postoperative radiotherapy breast/chest wall + regional lymph nodes;   Drug: Adjuvant trastuzumab;   Drug: Adjuvant letrozole (postmenopausal women);   Drug: Adjuvant tamoxifen + goserelin (premenopausal women);   Drug: Adjuvant palbociclib (if palbociclib given neoadjuvant);   Drug: Adjuvant Epirubicin+ Cyclophosphamide
17 Recruiting Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer
Conditions: Breast Cancer;   Metastasis to Liver;   Metastasis to Lung
Intervention: Radiation: stereotactic radiation therapy (SRT)
18 Recruiting Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Prophylactic radiation to the contralateral breast
19 Not yet recruiting A Registry Study of Breast Microseed Treatment
Condition: Breast Neoplasms
Intervention: Radiation: Permanent Breast Seed Implant (PBSI)
20 Recruiting Breast Cancer Toxicity
Condition: Breast Cancer Nos Metastatic Recurrent
Intervention: Procedure: blood sampling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.